Boston Scientific Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BSX research report →
Companywww.bostonscientific.com
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems.
- CEO
- Michael F. Mahoney
- IPO
- 1992
- Employees
- 53,000
- HQ
- Marlborough, MA, US
Price Chart
Valuation
- Market Cap
- $84.23B
- P/E
- 23.68
- P/S
- 4.09
- P/B
- 3.25
- EV/EBITDA
- 19.68
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 70.41%
- Op Margin
- 20.12%
- Net Margin
- 17.24%
- ROE
- 14.82%
- ROIC
- 9.90%
Growth & Income
- Revenue
- $20.07B · 19.87%
- Net Income
- $2.89B · 55.66%
- EPS
- $1.96 · 55.56%
- Op Income
- $3.97B
- FCF YoY
- 38.30%
Performance & Tape
- 52W High
- $109.50
- 52W Low
- $52.52
- 50D MA
- $62.34
- 200D MA
- $86.97
- Beta
- 0.62
- Avg Volume
- 16.56M
Get TickerSpark's AI analysis on BSX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 7, 26 | Zane Ellen M | other | 3,800 |
| May 7, 26 | WICHMANN DAVID S | other | 3,800 |
| May 7, 26 | Weber Christophe Pierre | other | 1,140 |
| May 7, 26 | Weber Christophe Pierre | other | 2,660 |
| May 7, 26 | Weber Christophe Pierre | other | 1,767 |
| May 7, 26 | Smith Cathy R | other | 2,209 |
| May 7, 26 | Smith Cathy R | other | 3,800 |
| May 7, 26 | Pegus Cheryl | other | 1,281 |
| May 7, 26 | Pegus Cheryl | other | 3,800 |
| May 7, 26 | Morano Susan E | other | 1,281 |
Our BSX Coverage
We haven't published any research on BSX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BSX Report →